Page last updated: 2024-09-04

tezosentan and Calcification, Pathologic

tezosentan has been researched along with Calcification, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Koivula, MK; Lehenkari, P; Leskelä, HV; Peltonen, T; Ruskoaho, H; Taskinen, P; Vuolteenaho, O	1

Other Studies

1 other study(ies) available for tezosentan and Calcification, Pathologic

Article	Year
Tezosentan inhibits uptake of proinflammatory endothelin-1 in stenotic aortic valves. The Journal of heart valve disease, 2012, Volume: 21, Issue:1 Topics: Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Cells, Cultured; Drug Repositioning; Endothelin A Receptor Antagonists; Endothelin-1; Female; Humans; Inflammation; Lipid Metabolism; Male; Middle Aged; Pyridines; Receptor, Endothelin A; Tetrazoles; Vasodilator Agents	2012

Article

Year

Tezosentan inhibits uptake of proinflammatory endothelin-1 in stenotic aortic valves.

The Journal of heart valve disease, 2012, Volume: 21, Issue:1

Topics: Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Cells, Cultured; Drug Repositioning; Endothelin A Receptor Antagonists; Endothelin-1; Female; Humans; Inflammation; Lipid Metabolism; Male; Middle Aged; Pyridines; Receptor, Endothelin A; Tetrazoles; Vasodilator Agents

2012